View Post

Five Days of G-CSF Adequate for Breast Cancer Chemo

In In The News by Barbara Jacoby

fiBy: Charles Bankhead, Senior Editor From: Five days of prophylactic granulocyte colony-stimulating factor (G-CSF) proved as effective as 7 to 10 days for preventing chemotherapy-induced febrile neutropenia in patients with early breast cancer, a randomized trial showed. Patients assigned to the 5-day regimen of filgrastim (Neupogen) had a 2.09% incidence of febrile neutropenia or treatment-related hospitalization per cycle of …